Consistent with in vitro findings, xenograft tumor tissues from ARPC1B-knockdown groups exhibited significantly reduced protein levels of β-catenin, p-GSK3β, c-Myc, and cyclin D1 (p < 0.05, Fig. 8E). The gene discussed is CCND1; the disease is neoplasm.